RPRX — Royalty Pharma Share News
0.000.00%
- $36.72bn
- $47.80bn
- $2.38bn
Royalty Pharma PLC reports results for the quarter ended in June - Earnings Summary
Brief: Royalty Pharma Q2 Net Income USD 351 Million
Royalty Pharma PLC expected to post earnings of 81 cents a share - Earnings Preview
Royalty Pharma PLC reports results for the quarter ended in March - Earnings Summary
Brief: Royalty Pharma Reports Q1 2023 Results
Brief: Royalty Pharma Q1 net income USD 509 million
Royalty Pharma PLC expected to post earnings of $1.27 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Energy firms, crypto stocks, Walt Disney
U.S. STOCKS ON THE MOVE-Cyclerion, banks, Jounce Therapeutics
U.S. STOCKS ON THE MOVE-Tesla, BrainStorm, Pinterest
Royalty Pharma up on $1 bln share-repurchase program
Brief: Royalty Pharma Announces $1 Bln Share Repurchase Program
UK's Puretech Health surges on royalty deal with Royal Pharma
Brief: PureTech Health Enters Into KarXT Royalty Agreement With Royalty Pharma For Up To $500 Mln
Brief: Royalty Pharma Raises Full-Year 2023 Guidance
U.S. FDA declines to approve Cytokinetics' heart drug
Royalty Pharma PLC reports results for the quarter ended in December - Earnings Summary
Brief: Royalty Pharma Reports Q4 And Full Year 2022 Results
Brief: Royalty Pharma Q4 adjusted EBITDA USD 983 million